TT
Triton Therapeutics, Inc.
SEC filingPharmaceuticals · Stamford, CT
Amount raised$36.4Msold at filing
Total offering$36.4M
Investors in the raise4count reported to the SEC
FiledOct 23, 2025first sale Oct 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Annie MitsakDirector
Timothy ShannonDirector
Elena GrigoryevaDirector
Paul FonteyneExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.